AlphaCrest Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,312
| Closed | -$675K | – | 1273 |
|
|
2022
Q2 | $675K | Sell |
3,312
-8,355
| -72% | -$1.7M | 0.03% | 846 |
|
|
2022
Q1 | $2.46M | Sell |
11,667
-5,784
| -33% | -$1.22M | 0.14% | 180 |
|
|
2021
Q4 | $4.19M | Buy |
17,451
+9,399
| +117% | +$2.26M | 0.16% | 132 |
|
|
2021
Q3 | $2.28M | Sell |
8,052
-1,377
| -15% | -$390K | 0.12% | 240 |
|
|
2021
Q2 | $3.27M | Sell |
9,429
-1,222
| -11% | -$423K | 0.14% | 196 |
|
|
2021
Q1 | $2.98M | Buy |
10,651
+3,305
| +45% | +$925K | 0.17% | 148 |
|
|
2020
Q4 | $1.8M | Buy |
+7,346
| New | +$1.8M | 0.15% | 162 |
|
|
2020
Q3 | – | Sell |
-8,651
| Closed | -$2.32M | – | 1089 |
|
|
2020
Q2 | $2.32M | Buy |
8,651
+5,718
| +195% | +$1.53M | 0.39% | 34 |
|
|
2020
Q1 | $928K | Sell |
2,933
-7,099
| -71% | -$2.25M | 0.11% | 310 |
|
|
2019
Q4 | $2.98M | Sell |
10,032
-5,275
| -34% | -$1.57M | 0.24% | 66 |
|
|
2019
Q3 | $3.56M | Buy |
15,307
+8,869
| +138% | +$2.07M | 0.22% | 73 |
|
|
2019
Q2 | $1.51M | Sell |
6,438
-540
| -8% | -$126K | 0.13% | 231 |
|
|
2019
Q1 | $1.65M | Buy |
6,978
+5,552
| +389% | +$1.31M | 0.25% | 75 |
|
|
2018
Q4 | $429K | Buy |
+1,426
| New | +$429K | 0.13% | 308 |
|